U.S. flag

An official website of the United States government

NM_005097.4(LGI1):c.1A>G (p.Met1Val) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Nov 8, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001289087.2

Allele description [Variation Report for NM_005097.4(LGI1):c.1A>G (p.Met1Val)]

NM_005097.4(LGI1):c.1A>G (p.Met1Val)

Gene:
LGI1:leucine rich glioma inactivated 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.33
Genomic location:
Preferred name:
NM_005097.4(LGI1):c.1A>G (p.Met1Val)
HGVS:
  • NC_000010.11:g.93758145A>G
  • NG_011832.1:g.5337A>G
  • NM_001308275.2:c.1A>G
  • NM_001308276.2:c.1A>G
  • NM_005097.3:c.1A>G
  • NM_005097.4:c.1A>GMANE SELECT
  • NP_001295204.1:p.Met1Val
  • NP_001295205.1:p.Met1Val
  • NP_005088.1:p.Met1Val
  • NC_000010.10:g.95517902A>G
  • NM_005097.2:c.1A>G
  • NR_131777.2:n.210A>G
Protein change:
M1V
Links:
dbSNP: rs202204627
NCBI 1000 Genomes Browser:
rs202204627
Molecular consequence:
  • NM_001308275.2:c.1A>G - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001308276.2:c.1A>G - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_005097.4:c.1A>G - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_001308275.2:c.1A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001308276.2:c.1A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005097.4:c.1A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_131777.2:n.210A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001476668Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Benign
(Nov 8, 2019)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis.

Trump N, McTague A, Brittain H, Papandreou A, Meyer E, Ngoh A, Palmer R, Morrogh D, Boustred C, Hurst JA, Jenkins L, Kurian MA, Scott RH.

J Med Genet. 2016 May;53(5):310-7. doi: 10.1136/jmedgenet-2015-103263. Epub 2016 Mar 18.

PubMed [citation]
PMID:
26993267
PMCID:
PMC4862068

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317

Details of each submission

From Athena Diagnostics, SCV001476668.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024